We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$141M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$127M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
MRK icon
Merck
MRK
+$97.7M
5
ZBH icon
Zimmer Biomet
ZBH
+$80.8M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WYNN icon
326
Wynn Resorts
WYNN
$10.6B
$7.32M 0.05%
101,912
+39,511
+63% +$3.13M
RCUS icon
327
Arcus Biosciences
RCUS
$3.66B
$7.29M 0.05%
+425,504
New +$9.51M
LEN icon
328
Lennar Class A
LEN
$20.6B
$7.28M 0.05%
92,013
-171,509
-65% -$12.2M
MO icon
329
Altria Group
MO
$109B
$7.2M 0.05%
+186,320
New +$7.75M
RNAC icon
330
Cartesian Therapeutics
RNAC
$265M
$7.16M 0.05%
96,285
+1,195
+1% +$91.6K
CAH icon
331
Cardinal Health
CAH
$55.5B
$7.12M 0.05%
151,597
-3,912
-3% -$201K
RPRX icon
332
Royalty Pharma
RPRX
$25.8B
$7.1M 0.05%
168,734
+112,028
+198% +$4.81M
JEF icon
333
Jefferies Financial Group
JEF
$12.8B
$7.05M 0.05%
410,023
+177,654
+76% +$2.91M
BBL
334
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$7.05M 0.05%
165,255
-453,440
-73% -$20.2M
SHLX
335
DELISTED
Shell Midstream Partners, L.P.
SHLX
$7.04M 0.05%
744,493
– –
PTVE
336
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$6.96M 0.04%
+548,402
New +$6.88M
ASMB icon
337
Assembly Biosciences
ASMB
$530M
$6.95M 0.04%
35,215
+5,386
+18% +$1.36M
DADA
338
DELISTED
Dada Nexus
DADA
$6.82M 0.04%
+257,595
New +$6.72M
GIB icon
339
CGI
GIB
$15.6B
$6.8M 0.04%
+100,494
New +$6.85M
HCA icon
340
HCA Healthcare
HCA
$89.6B
$6.78M 0.04%
54,348
-408,599
-88% -$50.6M
GFF icon
341
Griffon
GFF
$4.75B
$6.72M 0.04%
+343,867
New +$7.07M
PUMP icon
342
ProPetro Holding
PUMP
$1.43B
$6.69M 0.04%
1,648,054
– –
KRTX
343
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6.69M 0.04%
86,528
-23,852
-22% -$2.03M
FVRR icon
344
Fiverr
FVRR
$327M
$6.59M 0.04%
+47,455
New +$5.09M
TD icon
345
Toronto Dominion Bank
TD
$200B
$6.58M 0.04%
142,500
-15,281
-10% -$712K
EEFT icon
346
Euronet Worldwide
EEFT
$2.65B
$6.56M 0.04%
+71,987
New +$7.02M
AKAM icon
347
Akamai
AKAM
$16.9B
$6.54M 0.04%
59,181
-30,731
-34% -$3.41M
SNPR.U
348
DELISTED
Tortoise Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of
SNPR.U
$6.53M 0.04%
+600,000
New +$6.49M
MTX icon
349
Minerals Technologies
MTX
$2.32B
$6.52M 0.04%
127,612
-38,907
-23% -$1.92M
BEAM icon
350
Beam Therapeutics
BEAM
$2.82B
$6.5M 0.04%
264,116
-13,908
-5% -$345K
12 13
14
15 16

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.